JP2023538216A - 術後悪心嘔吐の療法 - Google Patents

術後悪心嘔吐の療法 Download PDF

Info

Publication number
JP2023538216A
JP2023538216A JP2023500302A JP2023500302A JP2023538216A JP 2023538216 A JP2023538216 A JP 2023538216A JP 2023500302 A JP2023500302 A JP 2023500302A JP 2023500302 A JP2023500302 A JP 2023500302A JP 2023538216 A JP2023538216 A JP 2023538216A
Authority
JP
Japan
Prior art keywords
amisulpride
use according
patient
bmi
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023500302A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022008901A5 (enExample
Inventor
クライブ ギルバート,ジュリアン
フォックス,ガブリエル
ウィリアム グリストウッド,ロバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acacia Pharma Ltd
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2010361.0A external-priority patent/GB202010361D0/en
Priority claimed from GBGB2108238.3A external-priority patent/GB202108238D0/en
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Publication of JP2023538216A publication Critical patent/JP2023538216A/ja
Publication of JPWO2022008901A5 publication Critical patent/JPWO2022008901A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023500302A 2020-07-06 2021-07-06 術後悪心嘔吐の療法 Pending JP2023538216A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2010361.0 2020-07-06
GBGB2010361.0A GB202010361D0 (en) 2020-07-06 2020-07-06 Therapy of post-operative nausea and vomiting
GB2108238.3 2021-06-09
GBGB2108238.3A GB202108238D0 (en) 2021-06-09 2021-06-09 Thearpy of post-operative nausea and vomiting
PCT/GB2021/051720 WO2022008901A1 (en) 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting

Publications (2)

Publication Number Publication Date
JP2023538216A true JP2023538216A (ja) 2023-09-07
JPWO2022008901A5 JPWO2022008901A5 (enExample) 2024-06-24

Family

ID=77021661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023500302A Pending JP2023538216A (ja) 2020-07-06 2021-07-06 術後悪心嘔吐の療法

Country Status (11)

Country Link
US (1) US20230263770A1 (enExample)
EP (1) EP4175631A1 (enExample)
JP (1) JP2023538216A (enExample)
KR (1) KR20230035095A (enExample)
CN (1) CN115867271A (enExample)
AU (1) AU2021305446A1 (enExample)
BR (1) BR112023000167A2 (enExample)
CA (1) CA3187665A1 (enExample)
IL (1) IL299649A (enExample)
MX (1) MX2023000283A (enExample)
WO (1) WO2022008901A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250152595A1 (en) * 2023-11-09 2025-05-15 Lisa Myslinski Medication to alleviate nausea with or without vomiting, vertigo, and pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201004020D0 (en) * 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
GB201702250D0 (en) * 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANESTHESIOLOGY, vol. 128, no. 6, JPN6025028213, 2018, pages 1099 - 1106, ISSN: 0005641846 *
ANESTHESIOLOGY, vol. 130, no. 2, JPN6025028215, 2019, pages 203 - 212, ISSN: 0005641848 *
BRITISH JOURNAL OF ANAESTHESIA, vol. 111, no. 6, JPN6025028214, 2013, pages 938 - 945, ISSN: 0005641847 *

Also Published As

Publication number Publication date
US20230263770A1 (en) 2023-08-24
IL299649A (en) 2023-03-01
BR112023000167A2 (pt) 2023-01-31
AU2021305446A1 (en) 2023-02-02
KR20230035095A (ko) 2023-03-10
MX2023000283A (es) 2023-02-09
CA3187665A1 (en) 2022-01-13
WO2022008901A1 (en) 2022-01-13
CN115867271A (zh) 2023-03-28
EP4175631A1 (en) 2023-05-10

Similar Documents

Publication Publication Date Title
JP7526244B2 (ja) 術後悪心嘔吐の救援治療
US20240050403A1 (en) Therapy of post-operative emesis with amisulpride
JP2023538216A (ja) 術後悪心嘔吐の療法
EA048577B1 (ru) Терапия послеоперационной тошноты и рвоты
HK40091212A (zh) 术後恶心和呕吐的疗法
HK40005558A (en) Therapy of post-operative emesis with amisulpride
JPWO2018146490A5 (enExample)
NZ792875A (en) Therapy of post-operative emesis with amisulpride
EA044539B1 (ru) Терапия постоперационной рвоты амисульпридом
HK40013552A (en) Rescue treatment of post operative nausea and vomiting
EA042759B1 (ru) Экстренное лечение постоперационной тошноты и рвоты

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240614

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250715

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251008